Skip to main content
Fig. 2 | Molecular Cancer

Fig. 2

From: Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development

Fig. 2

Identification of tumor antigens associated with CHOL prognosis. a Narrow-down analysis of potential tumor antigens with both amplified and mutated features (in a total of 1391 candidates), and significant OS and RFS prognosis (in a total of 3 candidates) in CHOL. b-c Kaplan-Meier OS (b) and RFS (c) curves comparing the groups with a different CD247 expression in CHOL. d-e Kaplan-Meier OS (d) and RFS (e) curves comparing the groups with a different expression of FCGR1A in CHOL. f-g Kaplan-Meier OS (f) and RFS (g) curves comparing the groups with a different expression of TRRAP in CHOL

Back to article page

Molecular Cancer

ISSN: 1476-4598